ATM and breast carcinoma: Mutations in moderate-risk genes ATM, CHEK2, PALB2, and RAD50 confer 2- to 4-fold increased breast cancer risks5, although recent evidence suggests that the breast cancer risk conferred by PALB2 mutations may be higher than initially thought6, 7.